Synageva BioPharma Closes $115 Mln Stock Offering

Synageva BioPharma Q4 12 Earnings Conference Call At 4:30 PM ET

Synageva BioPharma To Present At Cowen & Co. Conference; Webcast At 10:40 AM ET

Trade GEVA now with

7/13/2012 12:56 PM ET

Synageva BioPharma Corp. (GEVA: Quote) said Friday that it has closed a $115 million underwritten public offering of 2,792,200 shares of common stock, including 364,200 shares of common stock which were issued pursuant to the exercise of the underwriters' over-allotment option, at a price of $41.20 per share.

Morgan Stanley and J.P. Morgan acted as joint book-running managers in the offering, and Cowen and Company, Leerink Swann, Canaccord Genuity Inc. and Wedbush PacGrow Life Sciences acted as co-managers in the offering.

Click here to receive FREE breaking news email alerts for Synageva BioPharma Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 76 Articles Next>>

Editors Pick

Stocks May Move Lower As Upbeat Data Raises Fed Concerns - U.S. Commentary

After showing a substantial recovery over the course of the previous session, stocks are likely to come under pressure in early trading on Friday. The major index futures are currently pointing to a lower open for the markets, with the Dow futures down by 42 points.

Mailbox Now Comes To IPad

The popular e-mail management app Mailbox, developed by Orchestra Inc., has been updated to be compatible with Apple's iPad. Orchestra disclosed the news of the update through its official blog. "You asked, we listened. Mailbox is now available for iPad, so you can swipe your way to inbox zero on all your iOS devices," Orchestra's brief blog read.

German Business Morale Improves For First Time In 3 Months

Sentiment among German companies strengthened in May for the first time since February due to an improvement in current conditions, indicating that the economy remains on track despite a challenging environment. Moreover, the GfK survey forecast German optimism to reach its highest level in more than five years.